Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9150
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 191 $119,701 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $119,701 Current and potential, with all options
- Last date to order 11% complete
- IDV ceiling 2% used
- $4,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $499,999,999 single-award IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.
This IDC is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which aims to establish multiple regional prime vendor contracts to provide worldwide pharmaceutical support to the Department of Defense (DoD), United States Coast Guard, and other government agencies. The unrestricted, fully competitive solicitation for this program is expected to be issued in March 2024, with awards made on a regional basis to at least three different contractors across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet (CONUS/OCONUS) line items. Both primary and backup suppliers will be selected to provide separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally.
Task orders
Show 40 more
Latest 50 of 191 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D9150?
SPE2DR25D9150 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DR25D9150 worth?
Orders under SPE2DR25D9150 have obligated $119,701. SPE2DR25D9150's own ceiling is $4,999,999.
How many orders have been placed under contract SPE2DR25D9150?
191 orders have been placed under SPE2DR25D9150, the latest on July 15, 2026.
Who can order from contract SPE2DR25D9150?
SPE2DR25D9150 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9150 competed?
The extent of competition for SPE2DR25D9150 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV